A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study

Abroad (travel likely)RecruitingPHASE3

Conditions

Primary Open Angle Glaucoma (POAG) · Ocular Hypertension (OH)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • National Clinical Trials, Beverly Hills, California, United States

    Contact: Study coordinator (Shilo Rowlette) · shilo@nationalclinicaltrials.com · 702-720-7323
    Contact: Principal Investigator (James Khodabakhsh, Dr)
  • United medical research institute, Inglewood, California, United States

    Contact: Study coordinator (Carmen Caballero-Marin) · carmen@drjamespeace.com · 888-636-1062
    Contact: Principal Investigator (James H Peace, Dr)
  • Eye research foundation, Inc., Newport Beach, California, United States

    Contact: Study coordinator (Linda Wirta) · linda.wirta@drwirta.com · 949-650-1863
    Contact: Principal Investigator (David Wirta, Dr.)
  • Visionary Eye Research Institute, Newport Beach, California, United States

    Contact: Principal Investigator (Ehsan Sadri, Dr)
  • North Bay Eye Associates, Petaluma, California, United States

    Contact: Study coordinator (Dominiga Ferreyra) · dferreyra@northbayeye.com · 707-769-2237
    Contact: Principal Investigator (Jason Bacharach, Dr)
  • Advanced research, LLC, Boynton Beach, Florida, United States

    Contact: Study coordinator (Julia Conceicao) · jconceicao@advancedresearchfl.com · 954-302-3163
    Contact: Principal Investigator (Sirtaz Sibia, Dr)
  • Quantum clinical trials, Miami Beach, Florida, United States

    Contact: Study coordinator (Kiara Rugba) · kiara@qctrials.com · 786-774-1008
    Contact: Principal Investigator (Shani Reich, Dr)
  • Advanced research, LLC, Weston, Florida, United States

    Contact: Study coordinator (Jillene Moxam) · jmoxam@advancedresearchfl.com · 954-302-3047
    Contact: Principal Investigator (Aarub Kubal, Dr)
  • Clayton Eye Clinical Research, Morrow, Georgia, United States

    Contact: Study coordinator (Jahanzeb Khan) · HelenDuBiner@claytoneye.net · 770-968-8888
    Contact: Principal Investigator (Lauren Dubiner, Dr)
  • Coastal Research Associates, LLC, Roswell, Georgia, United States

    Contact: Study coordinator (John schcur) · john@coastalresearchassociates.com · 770-968-8888
    Contact: Principal Investigator (Douglas G Day, Dr)
  • The eye care institute, Louisville, Kentucky, United States

    Contact: Study coordinator (Daniela Castellanos) · danielleurbansky@eyecare-partners.com · 513-305-8654
    Contact: Principal Investigator (Brennan P Greene, Dr)
  • Tekwani vision center, St Louis, Missouri, United States

    Contact: Study coordinator (Lisa Dinsmore) · dinsmore.tvc@gmail.com · (314) 842-2020
    Contact: Principal Investigator (Navin Tekwani, Dr)
  • Ophthalmology associate (Eye care), St Louis, Missouri, United States

    Contact: Study coordinator (Danielle M Urbansky) · danielleurbansky@eyecare-partners.com · 314-966-3377
    Contact: Principal Investigator (Rajan P Malhotra, Dr)
  • Rochester Ophthalmological Group, Rochester, New York, United States

    Contact: Study coordinator (Rachel Rivera) · rogstudy4@rogeyecare.com · 585-244-6011
    Contact: Principal Investigator (Paul Hartman, Dr)
  • Houston Eye Associates, Houston, Texas, United States

    Contact: Study coordinator (Bhavna Shah, Dr) · bshah@HoustonEye.com · (832)-553-7113
    Contact: Principal Investigator (Kevin Y Jong, Dr)
  • R and R eye research, San Antonio, Texas, United States

    Contact: Study coordinator (Maggie Hazen) · maggie@eye-assoc.com · 210-424-2584
    Contact: Principal Investigator (Anhtuan Nguyen, Dr)